InsiderClue
Stocks · Health care · In Vitro & In Vivo Diagnostic Substances

Q/C TECHNOLOGIES, INC.

QCLS Clue Score25
United States Fiscal year ends December CIK 0001321834
$0.63 -1.05% Close, 9 Oct 2026
Alert on the numbers Alert on insider trades
Price $0.63 −91.47% Close, 9 Oct 2026

Closing prices at the end of each trading day, from 12 Oct 2016. Not a live quote. Adjusted for share splits, so the line has no step at a split; dividends are not added back.

Revenue and profit

What the business sells, and what is left of it. Point at a year for the detail.
RevenueOperating incomeNet income
Fiscal year 2016Revenue3.0Operating income−3.3Net income−3.3Fiscal year 2017Revenue3.4 +13.3%Operating income−6.6Net income−7.4Fiscal year 2018Revenue1.7 −50.4%Operating income−10.1Net income−10.8Fiscal year 2019Revenue1.6 −5.3%Operating income−3.5Net income−3.9Fiscal year 2020Operating income−9.5Net income−9.5Fiscal year 2021Operating income−28.8Net income−29.9Fiscal year 2022Operating income−15.3Net income−15.2EPS, diluted−11.74Fiscal year 2023Operating income−17.1Net income−4.0EPS, diluted−5.33Fiscal year 2024Operating income−10.2Net income−23.4EPS, diluted−1,080.87Fiscal year 2025Operating income−9.8Net income−11.6EPS, diluted−8.66
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue 3.0 3.4 1.7 1.6 n/a n/a n/a n/a n/a n/a
Growth +13.3% −50.4% −5.3%
Operating income −3.3 −6.6 −10.1 −3.5 −9.5 −28.8 −15.3 −17.1 −10.2 −9.8
Net income −3.3 −7.4 −10.8 −3.9 −9.5 −29.9 −15.2 −4.0 −23.4 −11.6
Growth
EPS, diluted n/a n/a n/a n/a n/a n/a −11.74 −5.33 −1,080.87 −8.66

Margins

How much of each dollar of revenue it keeps. Point at a year for the detail.
Gross marginOperating marginNet margin
Fiscal year 2016Gross margin63.4%Operating margin−112.4%Net margin−111.6%Free cash flow margin−145.1%Fiscal year 2017Gross margin28.3%Operating margin−197.1%Net margin−219.6%Free cash flow margin−153.1%Fiscal year 2018Gross margin7.6%Operating margin−604.0%Net margin−651.4%Free cash flow margin−514.6%Fiscal year 2019Gross margin30.4%Operating margin−220.2%Net margin−246.6%Fiscal year 2020Fiscal year 2021Fiscal year 2022Fiscal year 2023Fiscal year 2024Fiscal year 2025
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Gross margin 63.4% 28.3% 7.6% 30.4% n/a n/a n/a n/a n/a n/a
Operating margin −112.4% −197.1% −604.0% −220.2% n/a n/a n/a n/a n/a n/a
Net margin −111.6% −219.6% −651.4% −246.6% n/a n/a n/a n/a n/a n/a
Free cash flow margin −145.1% −153.1% −514.6% n/a n/a n/a n/a n/a n/a n/a

Cash flow

The cash the business makes, what it reinvests, and what it hands back. Point at a year for the detail.
Operating cash flowCapital expenditureFree cash flow
Fiscal year 2016Operating cash flow−4.2Capital expenditure−0.1Free cash flow−4.3Fiscal year 2017Operating cash flow−5.1Capital expenditure−0.1Free cash flow−5.1Fiscal year 2018Operating cash flow−8.5Capital expenditure−0.1Free cash flow−8.6Fiscal year 2019Operating cash flow−3.1Fiscal year 2020Operating cash flow−4.7Fiscal year 2021Operating cash flow−19.5Fiscal year 2022Operating cash flow−12.3Fiscal year 2023Operating cash flow−13.0Fiscal year 2024Operating cash flow−9.0Fiscal year 2025Operating cash flow−9.1Capital expenditure−1.8Free cash flow−10.8
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating cash flow −4.2 −5.1 −8.5 −3.1 −4.7 −19.5 −12.3 −13.0 −9.0 −9.1
Capital expenditure −0.1 −0.1 −0.1 n/a n/a n/a n/a n/a n/a −1.8
Free cash flow −4.3 −5.1 −8.6 n/a n/a n/a n/a n/a n/a −10.8
Growth

Balance sheet

What it holds against what it owes, at each year end. Point at a year for the detail.
Cash
Fiscal year 2016Cash0.1Shareholders’ equity3.4Fiscal year 2017Cash0.4Shareholders’ equity7.6Fiscal year 2018Cash0.2Shareholders’ equity5.8Fiscal year 2019Cash0.5Shareholders’ equity−2.3Fiscal year 2020Cash0.1Shareholders’ equity−5.3Fiscal year 2021Cash0.6Shareholders’ equity23.6Fiscal year 2022Cash0.7Shareholders’ equity14.7Fiscal year 2023Cash2.7Shareholders’ equity12.4Fiscal year 2024Cash0.2Shareholders’ equity9.8Fiscal year 2025Cash1.0Shareholders’ equity21.8
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Cash 0.1 0.4 0.2 0.5 0.1 0.6 0.7 2.7 0.2 1.0
Shareholders’ equity 3.4 7.6 5.8 −2.3 −5.3 23.6 14.7 12.4 9.8 21.8

In millions of USD, except per-share figures and ratios. Fiscal years, as last filed with the SEC.

Financial statements FY2025 · 10-K

Cash flow

In millions of USD, except per-share figures; shares in millions. Fiscal years ending December, each column as last filed with the SEC.
Click a line to chart it
Fiscal year FY2016 31 Dec 2016 FY2017 31 Dec 2017 FY2018 31 Dec 2018 FY2019 31 Dec 2019 FY2020 31 Dec 2020 FY2021 31 Dec 2021 FY2022 31 Dec 2022 FY2023 31 Dec 2023 FY2024† 31 Dec 2024 FY2025† 31 Dec 2025
Operations
−4.2 −5.1 −8.5 −3.1 −4.7 −19.5 −12.3 −13.0 −9.0 −9.1
Growth
0.3 0.2 0.2 0.1 0.0 n/a n/a n/a n/a n/a
Investment
−0.1 −0.1 −0.1 n/a n/a n/a n/a n/a n/a −1.8
calc −4.3 −5.1 −8.6 n/a n/a n/a n/a n/a n/a −10.8
Growth
calc n/a n/a n/a n/a n/a n/a n/a n/a n/a −6.25
3.8 −5.0 −0.4 −3.9 −8.8 19.9 6.9 1.8 −6.1 −8.4
Financing
n/a 10.5 9.1 7.0 4.7 0.1 5.6 13.1 12.6 18.3

† The diluted share count jumps at 2024 and 2025, so per-share figures either side of that column are not comparable. Usually a split, but the break lands on the restatement boundary rather than on the split date, because every column is that period’s latest filing.

Lines marked calc are worked out here from filed figures; point at one for how. Capital expenditure, dividends and buybacks are shown as money out, so negative.